文献速递精神分裂症与精神病性障碍

抗精神病药物治疗相关的DNA甲基化与组蛋白修饰:一项系统综述

DNA methylation and histone modifications associated with antipsychotic treatment: a systematic review.
PubMed 文献 · Mol Psychiatry · 2024-09-03

本系统综述纳入65项研究,评估抗精神病药物对表观基因组变化的影响,涵盖全局甲基化(9项)、全基因组甲基化(22项)、候选基因甲基化(16项)和组蛋白修饰(18项)。氟哌啶醇持续与全局高甲基化增加相关,氯氮平似乎促进表观基因组低甲基化;组蛋白修饰方面,氯氮平改变前额叶皮层组蛋白甲基化模式,利培酮和喹硫平对组蛋白标记的影响具有区域和细胞类型选择性。

要点

  • 氟哌啶醇持续与全局高甲基化增加相关,与全基因组分析结果一致。
  • 氯氮平似乎促进表观基因组低甲基化。
  • 利培酮降低纹状体H3K27ac,喹硫平改变前额叶皮层全局H3K9me2水平。

核心结论

  • 抗精神病药物对表观基因组变化具有选择性影响,呈现复杂且有靶向的作用模式。
  • 抗精神病药物与表观遗传学之间的复杂动态关系明确需要更详尽的探索。

研究设计与样本

  • 系统综述,共识别并评估65项研究,包括全局甲基化9项、全基因组甲基化22项、候选基因甲基化16项和组蛋白修饰18项。

主要发现

  • 氟哌啶醇持续与全局高甲基化增加相关,与主要采用甲基化芯片的全基因组分析结果一致。
  • 氯氮平似乎促进整个表观基因组的低甲基化。
  • 候选基因甲基化研究显示抗精神病药物治疗后效应不一,Glra1和Drd2频繁发生高甲基化,而SLC6A4、DUSP6和DTNBP1更可能在启动子区域表现出低甲基化。
  • 氯氮平改变前额叶皮层组蛋白甲基化模式,特别是升高Gad1基因处的H3K4me3,并通过修饰组蛋白乙酰化和与HDAC2酶相互作用影响mGlu2等基因的转录。
  • 利培酮降低纹状体H3K27ac,喹硫平改变前额叶皮层全局H3K9me2水平,显示抗精神病药物对组蛋白修饰具有选择性影响。

局限性

  • 抗精神病药物与表观遗传学之间的复杂动态关系明确需要更详尽的探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antipsychotic medications are essential when treating schizophrenia spectrum and other psychotic disorders, but the efficacy and tolerability of these medications vary from person to person. This interindividual variation is likely mediated, at least in part, by epigenomic processes that have yet to be fully elucidated. Herein, we systematically identified and evaluated 65 studies that examine the influence of antipsychotic drugs on epigenomic changes, including global methylation (9 studies), genome-wide methylation (22 studies), candidate gene methylation (16 studies), and histone modification (18 studies). Our evaluation revealed that haloperidol was consistently associated with increased global hypermethylation, which corroborates with genome-wide analyses, mostly performed by methylation arrays. In contrast, clozapine seems to promote hypomethylation across the epigenome. Candidate-gene methylation studies reveal varying effects post-antipsychotic therapy. Some genes like Glra1 and Drd2 are frequently found to undergo hypermethylation, whereas other genes such as SLC6A4, DUSP6, and DTNBP1 are more likely to exhibit hypomethylation in promoter regions. In examining histone modifications, the literature suggests that clozapine changes histone methylation patterns in the prefrontal cortex, particularly elevating H3K4me3 at the Gad1 gene and affecting the transcription of genes like mGlu2 by modifying histone acetylation and interacting with HDAC2 enzymes. Risperidone and quetiapine, however, exhibit distinct impacts on histone marks across different brain regions and cell types, with risperidone reducing H3K27ac in the striatum and quetiapine modifying global H3K9me2 levels in the prefrontal cortex, suggesting antipsychotics demonstrate selective influence on histone modifications, which demonstrates a complex and targeted mode of action. While this review summarizes current knowledge, the intricate dynamics between antipsychotics and epigenetics clearly warrant more exhaustive exploration with the potential to redefine our understanding and treatment of psychiatric conditions. By deciphering the epigenetic changes associated with drug treatment and therapeutic outcomes, we can move closer to personalized medicine in psychiatry.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Marques D, Vaziri N, Greenway SC, et al. DNA methylation and histone modifications associated with antipsychotic treatment: a systematic review. Mol Psychiatry. 2024. PMID: 39227433. doi:10.1038/s41380-024-02735-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。